Shengmin Lan

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

Si-Ye Chen, Yong Yang, Shu‐Nan Qi et al. · Leukemia · 2020 · 131 citations · Full text

Medicine, Oncology, Cancer Immunology +13

Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma

Yong Yang, Jian-Zhong Cao, Shengmin Lan et al. · JAMA Oncology · 2016 · 83 citations

Medicine, Oncology, Radiation Oncology +16

Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)

Xiu-Wen Deng, Jun-Xin Wu, Tao Wu et al. · Radiotherapy and Oncology · 2018 · 49 citations

Medicine, Oncology, Radiation Oncology +11

Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma

Xin Liu, Tao Wu, Su-Yu Zhu et al. · JAMA Network Open · 2019 · 48 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group

Tao Wu, Yong Yang, Su-Yu Zhu et al. · Blood Advances · 2018 · 32 citations · Full text

Medicine, Oncology, Radiation Oncology +12